The guidance clarifies what sponsors should consider when putting together an application for the validation of a NAM ...
The Trump administration is redoubling its efforts to phase out animal testing in drug development and seeking to develop new ...
March 18 (Reuters) - The U.S. Food and Drug Administration on Wednesday issued a draft guidance to help companies reduce animal studies of experimental drugs and adopt newer methods, such as computer ...
Health authorities in the U.S. are continuing their move away from animal testing in drug development, with the FDA signaling an openness to new approaches that haven’t been validated and the National ...
New draft guidance from the FDA is urging pharma companies to accelerate efforts to transition from animal testing to ...
Officials with the FDA have released a draft guidance that aims to help drug developers validate new approach methodologies (NAMs) that can be used in place of animal testing. Based on human-centric ...
The FDA has released a draft guidance outlining how drug developers can validate new approach methodologies (NAMs) as alternatives to animal testing in preclinical drug development. The guidance, ...
HHS has made reducing animal testing a priority over the past year. In April 2025, the FDA announced it would phase out the animal testing requirement for monoclonal antibodies. A few months later, ...
In April 2025, the FDA announced plans to shift biomedical research for monoclonal antibodies and other medications away from animal testing toward new approaches. One year later, much speculation ...
PETA’s youth group peta2 brought a virtual reality “abduction simulator” to Middle Georgia State University to raise awareness about animal testing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results